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hNmU-R1eptor 1 (hNmU-R1) is a member of G protein-coupled receptor family. For
structural determination of hNmU-R1, the production of hNmU-R1 in milligram amounts is a prerequisite.
Here we reported two different eukaryotic expression systems, namely, Semliki Forest virus (SFV)/BHK-21
and baculovirus/Spodoptera frugiperda (Sf9) cell systems for overproduction of this receptor. In the SFV-based
expression system, hNmU-R1 was produced at a level of 5 pmol receptor/mgmembrane protein and the yield
could be further increased to 22 pmol receptor/mg membrane protein by supplementation with 2% dimethyl
sulfoxide (DMSO). Around 8 pmol receptor/mg membrane protein could be achieved in baculovirus-infected
Sf9 cells. The recombinant hNmU-R1 from SFV- and baculovirus-based systems was functional, with a Kd
value of [125I] NmU-23 (rat) similar to that from transiently transfected COS-7 cells, where hNmU-R1 was
ﬁrst identiﬁed. With the aid of 1% n-dodecyl-β-D-maltoside (LM)/0.25% cholesteryl hemisuccinate (CHS), the
yield of functional hNmU-R1 could reach 80%. The recombinant receptor from Sf9 cells was puriﬁed to
homogeneity. The speciﬁc binding of the puriﬁed receptor to [125I] NmU-23 (rat) indicated that the receptor
is bioactive. This is the ﬁrst report of successful solubilization and puriﬁcation of hNmU-R1, and will enable
functional and structural studies of the hNmU-R1.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionNeuromedin U (NmU), a smooth muscle contracting peptide, was
ﬁrst isolated from porcine spinal cord as two bioactive peptides NmU-
25 and its cleavage product NmU-8 [1,2]. It has been subsequently
isolated from various species [3,4]. Recently, two human orphan G
protein-coupled receptors (GPCRs), hNmU-R1 and hNmU-R2, have
been identiﬁed as the receptors for NmU [5–7]. Both receptors, which
share approximately 50% amino acid identity, can couple to G protein
of the Galpha (q/11) and Galpha (i) subfamily [8]. hNmU-R1 is prima-
rily expressed in peripheral tissues, whereas hNmU-R2 is mainly
found in speciﬁc regions of central nervous system such as spinal cord.
The different distribution of NmU receptors suggests that they may
have different physiological functions and pharmacological activities., 5-Bromo-4-Chloro-3-Indolyl
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l rights reserved.However, the speciﬁc physiological role consequent to binding of the
NmU peptide to these two receptors is still unknown.
Elucidation of these functions can be addressed from determina-
tion of the crystal structure of NmU receptors. For the structural
determination by NMR or X-ray crystallography, substantial amounts
(milligram) of protein are required. However, like other GPCRs, hNmU-
R1 is present in minute amounts in natural cells and tissues. Thus,
overexpression of the receptor in heterogeneous expression systems
becomes a necessary strategy. Escherichia coil (E. coli) is a popular host
organism for expression of foreign proteins because of its low lost, fast
growth and simplicity of handling and scale-up. Despite these
advantages, the E. coli expression systemhas limitations for production
of mammalianmembrane proteins because of its lack of machinery for
post-translational modiﬁcations, different protein insertion and fold-
ing mechanisms from eukaryotic cells, as well as different membrane
lipid composition which may be required for protein function [9,10].
Even if expression as inclusion bodies is achieved, refolding these
proteins would be a challenge, given the current limited knowledge of
GPCR folding [11]. In contrast to E. coli, as eukaryotic expression sys-
tem, insect cells can perform post-translational modiﬁcations similar
to mammalian cells and are hosts of choice to express GPCRs at high
yield. High-level expression and puriﬁcation of pituitary adenylate
cyclase-activating polypeptide receptor, rhodopsin, P2Y12 receptor,
beta-adrenergic receptor and histamine H1 receptor have been
reported in baculovirus/Sf9 cells [12–16]. Semliki Forest virus (SFV)-
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rokinin-1 receptor, histamin H2 receptor, CB2 cannabinoid receptor
and α2B-adrenergic receptor, have been efﬁciently expressed in SFV-
based expression system [17–20].
Here, we report production of hNmU-R1 in two eukaryotic expres-
sion systems including SFV/BHK-21 cells and baculovirus/Sf9 cells. In
the SFV/BHK-21 cell expression system, the expression level of recom-
binant protein could be increased to a range of around 22 pmol recep-
tor/mgmembrane protein by adding cell differentiation inducer DMSO.
The recombinant receptor was then for the ﬁrst time successfully
solubilized frommembranes of BHK-21 and Sf9 cells. Furthermore, the
epitope-tagged receptor, produced from baculovirus-infected Sf9 cells,
was puriﬁed to homogeneity by a two-step procedure utilizing Ni-NTA
and monomeric avidin afﬁnity chromatographies.
2. Materials and methods
2.1. Materials
Restriction enzymes were obtained from New England Biolabs
GmbH (Frankfurt am Main, Germany). SP6 RNA polymerase, the cap
analog m7G (5′) ppp (5′) G, RNasin, and rNTPs were from Fermentas
(Leon-Rot, Germany). NmU-8 (porcine) and NmU-25 (human) were
obtained from Bachem (Weil am Rhein, Germany). [125I] NmU-23 (rat)
was provided by Phoenix Pharmaceuticals, Inc. (Karlsruhe, Germany).
LM, FOS-choline-12 (FOS-12), FOS-choline-14 (FOS-14), and FOS-cho-
line-16 (FOS-16)were fromAnatrace Inc. (Maumee, OH, USA). Octyl-β-
D-glucopyronoside (OG) was supplied by Glycon Biochemicals (Luck-
enwalde, Germany). Decanoyl-N-hydoxyethylglucamide (HEGA-10)
was from BIOMOL GmbH (Hamburg, Germany). Digitonin, CHS,
Monoclonal anti-polyhistidine antibody and Alkaline Phosphatase-
coupled anti-mouse IgG were from Sigma (Munich, Germany).
2.2. Expression of hNmU-R1 in BHK-21 cells using SFV
To produce hNmU-R1 in SFV-based expression system, hNmU-R1
cDNAwas ampliﬁed from plasmid Peak8 (Aventis, Frankfurt am Main,
Germany), using forward primer (5′CGGGATCCGCTTGCAATGGCAGT-
GCG3′) and reverse primer (5′GGACTAGT GGATGGATCGGTCTCTTG3′),
which introduced a BamHI site at the 5′ end and a SpeI site at the 3′ end
to facilitate cloning. The BamHI- and SpeI-digested PCR product was
inserted into pSFV2CAPhis10 vector digested with the same enzymes,
resulting in pSFV2hNmU-R1his10 (Fig. 1). Expression of the recombi-
nant receptor is driven from a subgenomic 26S promoter (PSG) con-
tained in the vector. The N-terminus of hNmU-R1 was in frame with a
viral capsid sequence as a translation enhancer and the C-terminus of
the receptor was fused with a His10 tag. In vitro transcription and in
vivo packaging of recombinant SFV particles were done as described
[17].
BHK-21 cellswere used for virus infection and recombinant recepor
production. BHK-21 cells were grown in 1:1 mixture of Dulbecco's
Modiﬁed Eagle's Medium (DMEM) and Iscove's medium containing
10% fetal calf serum (FCS) and 4mM glutamine. Cells weremaintained
at 37 °C with 5% CO2 in a humidiﬁed incubator. BHK-21 cells of 80%
conﬂuence were infected with the activated virus at a multiplicity ofFig. 1. Schematic representation of the expression constructs for production of hNmU-
R1. PSG, subgenomic promoter from SFV; cap, coding region for the capsid protein from
SFV as enhancer; his, coding region for 10 histidine residues; POL, baculovirus
polyhedrin promoter; mel, encoding region for signal sequence of honeybee melittin;
ﬂag, coding region for the ﬂag tag; bio, coding region for the biotinylation domain of the
transcarboxylase from Propionibacterium shermanii.infection (MOI) of 30, and harvested at 19 h post infection by
centrifugation at 500 ×g for 10 min at 4 °C. The pellet was washed
three times with PBS to remove the remaining infectious virus
particles, and resuspended in breaking buffer (25 mM Hepes, pH 7.4,
100 mM NaCl, l5 μg/ml aprotinin, 50 μg/ml bestatin, 10 μg/ml soybean
trypsin inhibitor, 1 mM phenymethylsulfonylﬂuoride (PMSF)) to a
density of 5×106 cells/ml. The cells were lysed by nitrogen cavitation
(Parr Instrument Co., Moline, IL, USA) at 500 psi (3.4 MPa) for 45 min
and centrifuged at 500 ×g for 10 min at 4 °C to remove intact cells. The
membrane pellet from ultracentrifugation (100,000 ×g for 1 h) was
resuspended in the breaking buffer supplemented with 6% glycerol.
2.3. Expression of hNmU-R1 in Sf9 cells using baculovirus expression
system
The coding region of hNmU-R1was ampliﬁed by PCR using forward
primer (5′CGGGATCCAGCTTGCAATGGCAGTGCG3′) and reverse primer
(5′CCGGAATTCGGATGGATCGGTCTCTTG3′), which introduced a BamHI
site at the 5′ end and an EcoRI site at the 3′ end. The PCR product was
cloned into expression vector pVLﬂaghis10bio, resulting in pVL-
ﬂaghis10hNmU-R1bio (Fig. 1). In this construct, hNmU-R1 was fused
with ﬂag and His10 tags at the N-terminus and biotinylation domain of
Propionibacterium shermanii transcarboxylase at the C-terminus. The
prepromelittin signal peptide from honeybee was used for proper
targeting of the recombinant receptor, and the polyhedrin promoter
was used to drive the expression of recombinant receptor. Recombi-
nant baculoviruses were obtained by cotransfection of 0.1 μg of
linearized BaculoGoldDNA (BDBiosciences, Heidelberg, Germany) and
0.4 μg of recombinant transfer vector using Lipofectin Reagent (Invi-
trogen GmbH, Karlsruhe, Germany). The recombinant viruses were
selected and ampliﬁed as described [21].
Sf9 cells were grown in TNM-FH medium with supplement of 5%
FCS, 50 μg/ml gentamycin and 10 μg/ml vitamin B at 27 °C. Sf9 cells at a
density of 2×106 cells/ml were infected with the recombinant viruses
at an MOI of 3. The cells were harvested at 72 h post infection if not
indicated otherwise, andused formembrane preparation as previously
described for BHK-21 cells.
2.4. Radioligand binding assay
Ligand binding assay was performed as modiﬁed [6]. Membranes
(1 μg of protein per assay) were incubated with different concentra-
tions (0.01–3 nM) of [125I] NmU-23 (rat) for 1 h at 4 °C in binding buffer
(25 mM Hepes, 0.005% Triton X-100, 100 mM spermidine, 5 μg/ml
aprotinin, 50 μg/ml bestatin, 10 μg/ml soybean trypsin inhibitor) in a
ﬁnal volume of 200 μl. Free and bound radioligands were separated by
rapid ﬁltration through 0.3% polyethylenimine-presoaked Whatman
GF/F Filters. The ﬁlters were washed three times with ice-cold water.
The bound radioactivity was quantitated using scintillation counter
(1470wizard,Wallac, Finland). Nonspeciﬁc bindingwas determined in
the presence of non-labeled 1 μM human NmU-25. Speciﬁc binding
was calculated by the difference between total binding and nonspeciﬁc
binding. The results were analyzed using KaleidaGraph 3.5 (Synergy
Software, Reading, PA, USA). Equilibrium dissociation constant (Kd)
and receptor density (Bmax) were calculated from the results of
saturation binding experiments.
The binding assay for the solubilized receptor was performed as
follows: 5 μl of solubilized aliquot was incubated with binding buffer
containing 10 nM [125I] NmU-23 (rat) in a ﬁnal volume of 50 μl for 1 h at
4 °C. The ﬁnal detergent concentrations were 0.1% LM, 0.3% OG, 0.3%
HEGA-10, 0.1% digitonin, 0.1% FOS-12, 0.01% FOS-14, 0.01% FOS-16, and
0.1% LM/0.025%CHS, respectively. Nonspeciﬁc bindingwas determined
in the presence of non-labeled 1 μMhumanNmU-25. The separation of
bound ligand from free ligand and their quantiﬁcationwere as same as
described above. For the puriﬁed receptor, 0.1% LM/0.025% CHS was
included in the assay buffer with 0.5 μg receptor.
Fig. 2. Immunoblot of the recombinant hNmU-R1 produced in BHK-21 cells (A) and in
Sf9 cells (B) with anti-His antibody. Each lane was loaded with 10 μg of membrane
protein. Lane 1, membranes from uninfected cells. Lane 2, membranes from
recombinant virus infected cells.
Fig. 3. Saturation curve of [125I] NmU-23 (rat) binding to membranes from BHK-21 cells
infected with SFV-hNmU-R1-his (A), and membranes from Sf9 cells infected by
recombinant baculovirus for 96 h (B). BHK-21 cells were harvested at 19 h post infection
and Sf9 cells were harvested at 96 h post infection. Data represent one of the two
independent experiments performed in triplicate.
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In order to ﬁnd the detergent that yielded the highest amount of
active receptor, we have tested both non-ionic and zwitterionic deter-
gents. The non-ionic detergentswere 1% LM,1% digitonin, 3%OG, and 3%
HEGA-10. The lipid-like zwitterionic detergents included: 1% FOS-12,
0.1% FOS-14, and 0.1% FOS-16. A combination of 1% LM and 0.25% CHS
was also tested. For protein solubilization, crude membranes were
resuspended in the ice-cold solubilization buffer (25 mMHepes, pH 7.4,
500 mM NaCl, l5 μg/ml aprotinin, 50 μg/ml bestatin, 10 μg/ml soybean
trypsin inhibitor, 1 mM PMSF) to a ﬁnal concentration of 5 mg/ml
protein, and incubated with different detergents at 4 °C in an end-over-
end rotator for 1 h. After centrifugation at 100,000 ×g for 1 h, the
supernatant was aliquoted and taken as solubilized fraction forWestern
blot and binding assays.
2.6. Puriﬁcation of hNmU-R1 produced in Sf9 cells
The solubilized fraction was applied to a Ni-nitrilotriacetic acid
(NTA) agrose column (Qiagen, Hilden, Germany) equilibrated with
buffer A (25mMHepes, pH 7.4, 500mMNaCl, 5mM imidazol, 0.5% LM/
0.125% CHS, l5 μg/ml aprotinin, 50 μg/ml bestatin, 10 μg/ml soybean
trypsin inhibitor, 1 mM PMSF). The column was washed with 10 vo-
lumes of buffer B (same as buffer A except that buffer B contained
50 mM imidazol and 0.1% LM/0.025% CHS). Finally, the receptor was
eluted with buffer C (25 mM Hepes, pH 7.4, 200 mM NaCl, 250 mM
imidazol, 0.05% LM/0.0125% CHS, l5 μg/ml aprotinin, 50 μg/ml bestatin,
10 μg/ml soybean trypsin inhibitor, 1 mM PMSF). In order to chelate
nickel ions released from the Ni-NTA afﬁnity matrix, which could
cause protein aggregation by binding to several His10 tags fused to
receptor molecules, 20 mM EDTA was added to the elution fraction
from theNi-NTA column. The elution fractionwas thenpassed through
a monomeric avidin column (Pierce, Bonn, Germany) equilibrated
with buffer D (same as buffer C without imidazol). After washing the
columnwith 10 volumes of buffer D, protein was eluted with buffer D
containing 2 mM biotin. For gel ﬁltration analysis, the elution fraction
from the monomeric avidin column was ﬁrst concentrated with a 50-
kDamolecular weight cut-off centricon (Ambion, Austin, TX, USA) and
then loaded to the Superose-6 size exclusion column on a SMART
system (GE Healthcare, Uppsala, Sweden).
2.7. SDS-PAGE and Western blotting
Protein concentration was determined using Bicinchoninic Acid
Protein Assay Kit (Pierce, Bonn, Germany). The proteins were resolved
by 10% SDS-PAGE and electro-transferred to PVDF membrane for
immunoblotting. The PVDF membrane was blocked with 5% non-fatmilk at room temperature for 1 h in PBST buffer (13.7mMNaCl, 2.7mM
KCl, 1.5 mM KH2PO4, 13 mM Na2HPO4, 1.5 mM NaN3, 0.02% Tween-20),
and followed by incubation with Monoclonal anti-polyhistidine anti-
body (1:5000 in PBST) at room temperature for 1 h. Themembranewas
washed three times and then incubated with Alkaline Phosphatase-
coupled anti-mouse IgG (1:10,000 in PBST) at room temperature for 1 h.
Finally, the PVDF membrane was developed in alkaline phosphate
buffer (100mMTris–HCl, pH9.5,100mMNaCl, 5mMMgCl2) containing
0.33 mg/ml 5-Bromo-4-Chloro-3-Indolyl Phosphate p-Toluidinium
(BCIP) and 0.165 mg/ml Nitro-Blue Tetrazolium Chloride (NBT).
3. Results
3.1. hNmU-R1 produced in SFV-infected BHK-21 cells
Following infection of BHK-21 cells with the recombinant viruses,
expression of hNmU-R1 was analyzed by Western blot using anti-His
Fig. 5. Solubilization of the hNmU-R1 receptor with different detergents from
membranes of BHK-21 cells infected by SFV-hNmU-R1-His. (A) Western blot analysis of
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corresponds to the expected molecular weight of 44.9 kDa based on
calculation of number of amino acids. The upper smearing band
around 80 kDa detected by anti-His antibody probably represents the
receptor in a homo-oligomerized form. In membrane preparations
from mock-infected BHK-21 cells, only a nonspeciﬁc band was
observed.
To analyze pharmacological properties of the recombinant hNmU-
R1, saturation binding assays were performed using [125I] NmU-23
(rat) as radio-ligand (Fig. 3A). In membranes of SFV2hNmU-R1his10-
infected BHK-21 cells, the saturation binding curvewas best ﬁttedwith
a single-site afﬁnity curve. [125I] NmU-23 (rat) bound the receptorwith
a high afﬁnity (a Kd value of 0.14±0.028 nM) and a high density (a Bmax
value of 5.5±0.81 pmol receptor/mg membrane protein). No speciﬁc
binding could be observed in membranes frommock-infected BHK-21
cells. The Kd value of the recombinant receptor was in good agreement
with that of hNmU-R1 expressed in COS-7 cells (Kd=0.3, 0.61 and
0.72 nM) [5,6].
3.2. Effects of cell differentiation inducers on the production of
hNmU-R1-his
After deﬁning an MOI of 30 and incubation time of 19 h as optimal
condition for expression, we tested effects of NmU-8 (porcine), DMSO,
trichostatin A (TSA) and sodium butyrate on the production of the
functional recombinant receptor. The results of one of two indepen-
dent experiments that had a similar pattern are shown in Fig. 4. Porcine
NmU-8 could increase protein production from 5 pmol receptor/mg
membrane protein to 13 pmol receptor/mg membrane protein.
Sodium butyrate, at a concentration of 2mM, had a similar stimulation
effect as porcine NmU-8, increasing hNmU-R1 production by approxi-
mately 2-fold. The level of hNmU-R1 was increased from 5 pmol/mg
protein to 15 pmol/mg protein by adding 200 ng/ml of TSA. Addition of
2% DMSO had the most dramatic effect in enhancing expression, as it
could increase hNmU-R1 production by four times, from 5 to around
22 pmol/mg protein. However, a combination of 2% DMSO and 100 nM
porcine NmU-8 did not have synergic effect on receptor yield.
3.3. Functional solubilization of hNmU-R1 produced in BHK-21 cells
infected with recombinant SFV
A critical step to obtain membrane proteins in an active, stable form
for biophysical and structural studies is efﬁcient solubilization. To
maximize solubilization efﬁciency of functional protein, extensiveFig. 4. Effect of different chemical reagents on the receptor production. Cells without
any chemical reagents (1), cells with 2% DMSO (2), cells with 100 nM NmU-8 (porcine)
(3), cells with combination of 2% DMSO and 100 nM NmU-8 (porcine) (4), cells with
2 mM sodium butyrate (5), and cells with 200 ng/ml TSA (6). BHK-21 cells were infected
with SFV-hNmU-R1 and the additives were added at the same time as virus. Infected
cells were harvest at 19 h post infection. The data shown here represent one of the two
independent experiments (performed in triplicate) with a similar pattern.
solubilized proteins. (B) Speciﬁc binding of [125I] NmU-23 (rat) to the solubilized hNmU-
R1. Membrane proteins at a concentration of 5 mg/ml were incubated with different
detergents at 4 °C for 1 h. After centrifugation at 100,000 ×g for 1 h, the same volume
aliquots of the supernatants were used for Western blot and ligand binding assays.efforts were made to screen a broad range of detergents including
non-ionic and zwitterionic detergents. Most of the detergents did not
show considerable effect on solubilization as revealed by Western blot
analysis (data not shown), with the exception of few that were selected
for further studies. In addition, other detergents that were proved to be
gently mild to maintain membrane protein structure and functionwere
included [22,23]. The list comprised the following detergents: 1% LM, 3%
OG, 3% HEGA-10, 1% digitonin,1% FOS-12, 0.1% FOS-14, and 0.1% FOS-16.
FOS-cholines have beenwidely used for NMR conformational studies of
membrane proteins because its phosphocholine headgroup mimics
membrane environment [24]. Our results showed that FOS-cholines are
efﬁcient solubilizers in terms of total receptor, as demonstrated by a
dominantly intensive band from Western blot analysis (Fig. 5A).
However, low speciﬁc binding suggested that these detergents are not
suitable for solubilization of the receptor in the functional form due to
inactivation of part of the receptor. OG, one of the most successful
detergents used in crystallization of membrane proteins, showed a
Table 1
Puriﬁcation of the hNmU-R1
Fraction Total protein
(mg)
Speciﬁcity
(pmol/mg)
Yield
(%)
Puriﬁcation
fold
Membranes 410 8.5 100 1
Solubilized membranes 105 27 81 3
Elution from Ni-NTA 0.85 295 7.1 34
Elution from monomeric avidin 0.09 1520 3.9 178
The amount of receptor present in the different fractions was determined in the
presence of 10 nM [125I]NmU-23 (rat). Protein concentration was determined with
bicinchoninic acid using bovine serum albumin as standard.
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(Figs. 5A and B). Digitonin, which is another mild detergent widely used
for solubilization of membrane proteins [25,26], had solubilization
ability of total receptor similar to LMandHEGA-10 (Fig. 5A). However, in
terms of active receptor, LM showed the highest yield (28%). Combina-
tion of 1% LM and 0.25% CHS could further improve the yield of
functional protein to around 80%. Thus a combination of 1% LM and
0.25% CHS was used for solubilization in the following studies.
3.4. Expression of hNmU-R1 in Sf9 cells
An expression vector pVLﬂaghis10hNmU-R1bio was constructed.
The very late promoter polyhedrin of Autographa californica nuclear
polyhedrosis virus (ACNPV) was used to drive the expression of re-
combinant receptor. The recombinant baculoviruses were used to in-
fect insect Sf9 cells at an MOI of 3. Comparing to the membranes from
mock-infected cells, the membranes from the recombinant viruses-
infected cells showed a major band of 60 kDa (Fig. 2B), which
corresponds to the size of recombinant hNmU-R1 fusion protein (ﬂag
tag 1.0 kDa+His10 tag 1.4 kDa+hNmU-R1 44.9 kDa+bio tag 12.4 kDa).
This also indicated the complete processing of the prepromelittin
signal sequence in vivo. Maximal binding capacity of 8±1.1 pmol
receptor/mg membrane protein was observed at 72 h post infection.
Saturation binding of [125I] NmU-23 (rat) to cell membranes showed
that the recombinant receptor has a single binding site, with a Kd value
of 0.29±0.016 nM (Fig. 3B), which was similar to that obtained for the
receptor expressed in BHK-21 cells.
3.5. Puriﬁcation of hNmU-R1 produced in Sf9 cells infected with the
recombinant baculovirus
Solubilization of Sf9 membranes containing the recombinant
receptor was done with 1% LM/0.25% CHS as described above. After
two-column chromatography puriﬁcation, the receptor was nearly
pure as shown by silver stained SDS-PAGE gel (Fig. 6A). Themajor band
of approximate 60 kDa detected by Western blot analysis (Fig. 6B),
represented the puriﬁed receptor. The two minor bands of slightly
higher molecular mass did not cross-react with the anti-His antibody,
suggesting that they are contaminants from the afﬁnity column. The
ﬁnal yield of puriﬁed receptor from 105 mg solubilized fraction was
96 μg as revealed by protein quantiﬁcation of the puriﬁed receptor
(Table 1). Using [125I] NmU-23 (rat) as ligand, saturation binding assay
was attempted. However, due to inability to obtain a high concentra-
tion of [125I] NmU-23 (rat), the ligand could not saturate the receptor.
This indicated that the puriﬁed receptor is in a low afﬁnity state. If theFig. 6. Puriﬁed hNmU-R1 from Sf9 cells by Ni-NTA and monomeric avidin column.
Proteins were separated by 10% SDS-PAGE and analyzed by silver staining (A) or
Western blot against anti-His antibody (B). One microgram of puriﬁed hNmU-R1 was
loaded to the gel. Lane 1, puriﬁed hNmUR1. Lane 2, protein marker.Kdwas taken as 0.3 nM, the speciﬁc activity of the puriﬁed hNmU-R1 in
the presence of 10 nM [125I] NmU-23 (rat) was 1520 pmol/mg protein.
As the receptor is of lowafﬁnity, the datawould underestimate the real
activity of the receptor. To verify its homogeneity, the puriﬁed protein
was concentrated and analyzed by analytical gel ﬁltration column in a
SMART system. The elution proﬁle displayed a single peak (Fig. 7),
indicating that the puriﬁed receptor is in a homogeneous form.
4. Discussion
GPCRs constitute the largest group of integral membrane protein
superfamily in human [27]. With the exception of bovine rhodopsin,
which is abundant in natural source (300 mg per 200 bovine retina's)
and represents one of the most stable and detergent-tolerant GPCRs
[28], most of the GPCRs are produced in a very limited amount in their
natural tissues and cells. Thus, a heterogeneous expression system is
required to achieve adequate amount of proteins for structural studies.
Although there are examples of GPCRs overexpressed at a high level
[12–19,22,29], it is difﬁcult to outline general rules for a successful
overproduction of a desired membrane protein [9]. The expression
level for a given GPCRs is signiﬁcantly different from one system to
another, therefore, trial and error experiments are always necessary for
production of a speciﬁc protein.
hNmU-R1 expressed in Sf9 cells using baculovirus expression
system had a similar binding afﬁnity to [125I] NmU-23 (rat) as the
receptor from SFV-infected BHK-21 cells. However, the detected bind-
ing sites of around 8 pmol/mgmembrane proteinwere less than that of
hNmU-R1 from BHK-21 cells, demonstrating the variable capacity of
different expression systems for production of the same protein. With
the aim of acquiring sufﬁcient material for structural studies, scale-up
of the cell culture for large amount of protein production is required.
Despite less binding sites in Sf9 cells, baculovirus expression system is
still our choice for production of this receptor. Firstly, comparing to
BHK cells (at a density of 1×106 cells/ml), Sf9 cells can grow to a higherFig. 7. Gel ﬁltration analysis of puriﬁed hNmU-R1 produced from Sf9 cells. Twenty-ﬁve
microgram of the elution fraction from monomeric avidin column was applied to
Superose-6 column and elution of the protein was monitored at 280 nm.
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of active receptor can be obtained in Sf9 cells instead of around 85 μg of
active receptor in BHK-21 cells. Secondly, once the recombinant bacu-
lovirus is produced and veriﬁed, it can be easily multiplied from stock
virus by infecting insect cells. In contrast, due to biosafety reasons,
recombinant SFV has been modiﬁed to replication-deﬁcient type,
therefore, it cannot be propagated after infecting the cells. The recom-
binant SFV has to be prepared from in vitro transcribedmRNA for each
infection. Thus SFV preparation is time-consuming and costly. Fur-
thermore, a high MOI of 30 had to be used for high-level production of
hNmU-R1 in BHK-21 cells, which made SFV-based system unsuitable
for large-scale production of the receptor.
Interestingly, DMSO, TSA, and sodium butyrate could enhance
hNmU-R1 production in SFV-infected BHK-21 cells. They have been
reported to enhance gene expression in several systems. In mammalian
expression system, sodium butyrate enhanced expression level of diffe-
rent tissue plasminogen activators from 2- to 9-fold in CHO cells, andD6
chemokine receptor by 10-fold in L1.2 murine pre-B cell line [30,31]. An
increase of reporter expression was also observed in baculovirus-
transducedmammalian cells by addition of sodiumbutyrate or TSA [32].
In dipteran Drosophila melanogaster S2 cells and lepidopteran Tricho-
plusia ni BTI Tn 5B1-4 cells, supplement of DMSO and sodium butyrate
could enhance expression of human cyclooxygenase and tumstatin
[33,34]. TSA and sodium butyrate even reactivated silenced, virally
transduced genes in a manner that is neither promoter nor cell-type-
speciﬁc [35]. As histone deacetylase inhibitors, TSA and sodiumbutyrate
can cause hyperacetylation of histone, relaxation of chromatin structure.
The change of the chromatin structure is supposed to correlate with
activating gene transcription and increasing protein expression [33,36].
However, for SFV-based expression system, the mechanism is different.
The recombinant virus directly starts synthesis of its own proteins as
well as the recombinant receptor once it enters host cells. Thus TSA and
sodium butyrate cannot be directly involved in the recombinant protein
production at transcription level. They might indirectly increase
recombinant protein production by improving production of other
proteins, which are usually insufﬁcient for translocation and modiﬁca-
tion of quickly synthetic recombinant protein. Recently, it has been
reported thatDMSO in the culturemediumcan signiﬁcantly improve the
functional expression level of recombinant GPCRs in Pichia pastoris. Out
of 20 tested GPCRs, DMSO could improve functional expression of 16
GPCRs up to 6-fold [37]. DMSO can also increase the functional expres-
sion of human bradykinin receptor in BHK-21 cells, and hNmU-R2 in
BHK-21 cells and in P. pastoris [38,39]. It has been reported that DMSO
can alter the expression pattern of yeast [40], and upregulate genes
involved in lipid synthesis [41]. The exact mechanism of DMSO in
enhancing recombinant protein production is still unknown. However,
DMSO may improve protein production by stabilizing proteins as
suggested [33]. In contrast to the beneﬁcial effect of DMSO, TSA and
sodium butyrate on production of functional recombinant hNmU-R1 in
BHK-21 cells, the same was not observed in Sf9 cells infected with
recombinant baculoviruses, suggesting cell-speciﬁc dependence of
these agents on the functional protein production.
Detergents play an important role in studies of membrane protein
structure and function. They are indispensable as solubilizing agent to
extractmembrane proteins from their native lipid bilayer environment
for subsequent puriﬁcation and crystallization. The transfer of mem-
brane proteins from amembrane environment to a detergent environ-
ment may result in a loss of function, which is strongly detergent-
dependent [42]. The choice of detergents, buffer composition, and
ionic strength has an important effect on the solubility efﬁciency and
function of a speciﬁc protein. Because no literature was found for the
solubilization of hNmU-R1, a series of detergents had to be tested.
Among our selected detergents, LM was the most efﬁcient in solu-
bilizing hNmU-R1 fromBHK-21 cellmembranes in the functional form.
Addition of 0.25% CHS to solubilization reaction in the presence of 1%
LM could result in high recovery of functional receptor (around 80%).The benign effect of CHS on improvement of solubilization recovery
has been reported [22,43–45]. It was suggested that its structural
similarity to cholesterol contributes to protein integrity, function and
stability [45,46].
The recombinant hNmU-R1 produced in Sf9 cells was puriﬁed by
two-column chromatographies. Amajor band of around 60 kDa by silver
staining and Western blot veriﬁed that the intact receptor had been
obtained. The sharp peak from the analytic gel ﬁltration showed the
homogeneityof the receptor. Theunresolveddissociation constantof the
puriﬁed receptor, whichwas limited by reaching a high concentration of
[125I] NmU-23 (rat), indicated that the puriﬁed receptor is in a low
afﬁnity state, which could be caused by delipidation during the puri-
ﬁcation step. It is known that some cofactors and lipids bound to protein
can affect the binding properties of recombinant GPCRs and the loss of
such cofactors during puriﬁcation step could lower the speciﬁc activity
of otherwise fully active receptor [15,47,48]. However, the speciﬁc
binding of [125I] NmU-23 (rat) to 1520 pmol/mg protein (the Kd is taken
as 0.3 nM) indicated that the puriﬁed hNmU-R1 is bioactive. The
functional study of the puriﬁed receptor will be further investigated by
adding different lipids to the radio-ligand binding assay or by [35S]
GTPγS assay using reconstituted receptor.
In conclusion, functional recombinant hNmU-R1 could be pro-
duced in both SFV/BHK-21 cell and baculovirus/Sf9 cell expression
systems. Cell differentiation inducers were shown to enhance the level
of the receptor produced in BHK-21 cells. Due to its lower cost, growth
to a higher cell density and scale-up capacity, the baculovirus system is
favored for large-scale production of the protein for structural studies
in future. The receptor was successfully solubilized with LM/CHS, and
puriﬁed to homogeneity from Sf9 cell membranes. To our knowledge,
this is the ﬁrst report on the solubilization and puriﬁcation of hNmU-
R1, and it opens possibilities for biophysical and structural studies.
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